药物性肝病

被引：13

作者：

陈成伟

机构：

[1] 南京军区肝病临床研究中心

来源：

肝脏 | 2012年 / 17卷 / 05期

关键词：

D O I：

10.14000/j.cnki.issn.1008-1704.2012.05.029

中图分类号：

R595.3 [药源性疾病];

学科分类号：

100201 [内科学];

摘要：

<正>目前药物性肝损伤(DILI)越来越引起人们重视。DILI是发达国家急性肝功能衰竭(ALF)的首要病因,也是美国食品药品监督管理局(FDA)对药物采取警示的最常见原因。发展为ALF者,自然恢复率仅约25%。DILI的发生率约为1/10000～1/1000000暴

引用

页码：297 / 300

页数：4

共 5 条

[1]

药物性肝炎组织病理学评分探讨 [J].

胡锡琪 .

肝脏, 2010, 15 (05) :317-319

[2]

Mitochondrial Superoxide Dismutase and Glutathione Peroxidase in Idiosyncratic Drug-Induced Liver Injury [J].

Lucena, M. Isabel ;

Garcia-Martin, Elena ;

Andrade, Raul J. ;

Martinez, Carmen ;

Stephens, Camilla ;

Ruiz, Jhon D. ;

Ulzurrun, Eugenia ;

Carmen Fernandez, M. ;

Romero-Gomez, Manuel ;

Castiella, Augustin ;

Planas, Ramon ;

Antonio Duran, Jose ;

Melcon De Dios, Ana ;

Guarner, Carlos ;

Soriano, German ;

Borraz, Yolanda ;

Agundez, Jose A. G. .

HEPATOLOGY, 2010, 52 (01) :303-312

[3]

Causality Assessment in Drug-Induced Liver Injury Using a Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method [J].

Rockey, Don C. ;

Seeff, Leonard B. ;

Rochon, James ;

Freston, James ;

Chalasani, Naga ;

Bonacini, Maurizio ;

Fontana, Robert J. ;

Hayashi, Paul H. .

HEPATOLOGY, 2010, 51 (06) :2117-2126

[4]

Causality Assessment in Drug-Induced Liver Injury [J].

Hayashi, Paul H. .

SEMINARS IN LIVER DISEASE, 2009, 29 (04) :348-356

[5]

Incidence of drug-induced liver injury in medical inpatients [J].

Meier, Y ;

Cavallaro, M ;

Roos, M ;

Pauli-Magnus, C ;

Folkers, G ;

Meier, PJ ;

Fattinger, K .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (02) :135-143

← 1 →